Biotech and Life Science Resident Companies:
ActiveClean by CleanSpot, Inc.
Chuck Call, CEO
CleanSpot is developing a revolutionary product for limiting the spread of germs from, for example, kitchen counter tops, touch screen displays, public restrooms and ATM machines. The CleanSpot spray-on or wipe-in coating is designed leave a residual semi-durable coating on the frequent-touched surface after a normal cleaning process. The coating reduces the viability of microbes in between cleanings, and depending on how often the surface is touched, allows for less frequent cleaning.
Federica Pericle, PhD, MBA, President and CEO
Agilvax develops novel vaccines targeting infectious diseases and immunotherapies to combat cancer utilizing its proprietary virus-like particle (VLP) platform technology. The company has a pipeline and platform that is based on VLPs derived from RNA bacteriophage that have been engineered to incorporate novel peptide epitopes. The platform allows the company to rapidly identify ideal VLP candidates, moving from hypothesis to preclinical proof of concept in months.
Aqua Access, LLC
Rodney Herrington, President and Founder
Aqua Access was founded to develop affordable, reliable and energy efficient technologies to increase water availability worldwide.
GRADUATE: Avisa Pharma™ Inc.
David S. Joseph, President and CEO
Avisa Pharma™ Inc. is a clinical stage company developing a proprietary, point of care biomarker BreathTest™ that detects bacterial load, and monitors treatment response of urease producing pathogens in the lungs, rapidly and in real time. These pathogens cause significant morbidity/mortality in patients with Cystic Fibrosis (CF), Ventilator Associated Pneumonia (VAP) and Tuberculosis (TB).
Mary J. Ortner, PhD, MBA, President and CEO
Biophagy develops pharmaceutical products that restore autophagy, processes the human cell uses to isolate, degrade and recycle damaged components and pathogens that are implicated in infections, cancer, aging, and neuro-degeneration.
Reza Shekarriz, Ph.D., Director
Exhalix is developing a low-cost, proprietary biomarker-based non-invasive detection system for early diagnosis and monitoring of Peripheral Artery Disease (PAD). PAD is a life-threatening circulatory condition that results from arterial constriction and obstruction of blood flow to the organs and limbs. It is estimated that one in every 20 Americans over the age of 50 suffer from PAD, most of which are not diagnosed until PAD has progressed to later stages requiring more advanced treatment modalities. Untreated PAD is dangerous because of the increased risk for limb loss, kidney damage, coronary artery disease, stroke and heart attack. More accessible diagnosis and monitoring of PAD is expected to have a major impact on the cost of healthcare for patients, taxpayers, and insurance providers.
GRADUATE: Green Theme Technologies, LLCP
Gary S. Selwyn, CEO
Green Theme Technologies LLC develops and licenses cost-effective and environmentally-safe, natural and synthetic polymer treatments for fabric, plastic, paper and nonwoven materials. These treatments include super-hydrophobicity, anti-microbial properties, safe application of pesticides and insect-repellent chemicals, performance biometrics and medical applications.
James Studer, P.E., Managing Principal
InfraSUR is a technical services, strategic consulting, and technology development and licensing firm focused on environmental/public health, energy, and infrastructure security markets. R&D programs includes environmental biotechnology and on-going enhancements to the patented Biogeochemical Reductive Dehalogenation and Metals Stabilization (BiRDS) technology. InfraSUR offers technical leadership in in-situ environmental remediation for private sector and government clients in the United States and Canada.
Hafiz Hassan, Co-Founder & CTO
Interfasys develops ready-to-use lab Software that can be tailored to fit any specific environment. From Specimen Receiving through Lab Processes & Instrument Interfaces through Approval & Reporting – the entire lab workflow is automated.
Ries Robinson, MD, CEO
Medici Technologies provides predictive algorithm development and data analytics services, designed to enable companies to transform the data they have into the product they want. Medici accelerates client progress toward goals using a structured approach that incorporates project management, parallel algorithmic assessment, optimization, robustness testing, and validation. This systematic approach solves difficult, complex multivariate, life science algorithm problems.
Stuart Rose, Ph.D., CEO
PaizaBio is a New Mexico-based contract manufacturing organization (CMO) and marketing agent that provides Western pharmaceutical companies with high-level support and rapid entry into the rapidly growing Chinese aseptic drug market. Operating under the vision of “In China, For China, To Western Standards,” PaizaBio is committed to quality, integrity and an innovative approach to products and services, including Asia’s first dedicated “Sterile University” training program.
William Radigan, Founder
Radigan Engineering exists to help you solve your most challenging technical problems. As a licensed Professional Engineer and Certified SolidWorks Expert, the chances are good that I can help you model your system, analyze it, and make it work! If you have a great idea and need some help putting together a prototype, that’s my specialty. If you already have your great idea in production but something isn’t working as well as it should, I can help with that too.
Respira Therapeutics, Inc.
Robert M. Curtis, President and CEO
Respira Therapeutics, Inc., is an inhaled pharmaceutical company developing prescription drug-device products using its “best in class ”Axially Oscillating Sphere (AOSTM) dry powder inhaler (DPI) technology. The AOS-DPI platform, can target 1.4 to 2.5 times more drug to the lung than commercially available DPI technologies. Respira’s first pipeline product is an inhaled formulation of an off patent PDE5i drug, for treating various forms of pulmonary hypertension, a serious, progressively debilitating pulmonary vascular disease. Respira plans to commence FDA preclinical testing in 2017 and an initial clinical program in 2018. Respira is also investigating applications of its AOS-DPI to develop additional off-patent drugs to treat other serious pulmonary and systemic diseases. Respira was founded in 2010 by NM based Cottonwood Technology Fund with additional investment has been provided to date by Sun Mountain Capital, private individuals, and United Therapeutics Corporation, a leading pulmonary hypertension pharmaceutical firm.
Southwest Medical Ventures
Waneta Tuttle, CEO
Southwest Medical Ventures is an entrepreneurial venture development company that creates and builds start-up companies in the life sciences and health care. SWMV companies include Oligocide, PhDx Systems, Exagen Diagnostics, nanoMR, Azano Pharmaceuticals and Agilvax.
Les Stewart, CEO; Mary J. Ortner, PhD, MBA, Chief Business Officer
SolaranRx, Inc. is commercializing a platform of new therapies and companion imaging agents for the treatment of advanced (metastatic) melanoma. Among the most aggressive forms of metastatic cancer, melanoma has a one-year mortality of 75% if not caught early—thus making it an area of high unmet medical need. SolaranRx’s lead compound is a novel peptide that demonstrates highly specific binding to melanoma cells. When linked to a radioactive moiety, physicians can determine a patient’s suitability for treatment and then provide highly targeted radioactivity to attack the cancer cells. This merger between therapeutics and diagnostics—often referred to as theranostics—constitutes a new level of personalized medicine for advanced melanoma.
TimeLike Systems, LLC
Steve Coy, CEO
TimeLike Systems is a small company offering products and services related to computer simulation of complex systems in general, and of advanced optical systems in particular. TimeLike Systems is currently working to develop and commercialize two software tools: TimeLikeTM, a component-based software framework with integrated support for general purpose modeling and simulation, and LightLikeTM, a TimeLike-based tool for high fidelity simulation of advanced optical systems.
Anchor Resident Companies:
Logical Marketing, LLC
Lynore Abbott, Founder
Logical Marketing was founded to serve a growing need in technology product companies for a pay-as-you-go Marketing Department. With a broad range of expertise in strategy + tactics + execution, we provide focused, profitable results.
Sara Douglas & Company
Sara Douglas, MBA, ACC, CPCC
A versatile leadership coach, speaker and trainer, Sara uses a unique blend of “hard” (business) and “soft” (EQ: emotional intelligence) skills to help growth-seeking entrepreneurs build thriving businesses. She also assists achievement-oriented professionals make successful career transitions, often into entrepreneurship.